| SEC Info | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 4/23/07 Sierra Health Services Inc PREM14A 4/20/07 1:208 Merrill Corp-MD/FA
Document/Exhibit Description Pages Size
1: PREM14A Preliminary Proxy Solicitation Material -- Merger HTML 1,104K
or Acquisition
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement
Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
|
Filed by the Registrant x |
|
|
Filed by a Party other than the Registrant o |
|
|
Check the appropriate box: |
|
|
x |
Preliminary Proxy Statement |
|
o |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
o |
Definitive Proxy Statement |
|
o |
Definitive Additional Materials |
|
o |
Soliciting Material Pursuant to §240.14a-12 |
|
SIERRA HEALTH SERVICES, INC. |
||
|
(Name of Registrant as Specified In Its Charter) |
||
|
|
||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
||
|
|
||
|
Payment of Filing Fee (Check the appropriate box): |
||
|
o |
No fee required. |
|
|
x |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
|
(1) |
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
(2) |
Aggregate number of securities to which transaction applies: |
|
|
|
55,411,265 shares of Company common stock; 1,649,963 shares subject to outstanding Company stock options; 538,033 shares subject to outstanding Company restricted stock units; and 2,213,669 shares subject to outstanding convertible debentures |
|
|
|
|
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
|
|
|
|
(4) |
Proposed maximum aggregate value of transaction: |
|
|
|
$2,580,099,443.03 |
|
|
(5) |
Total fee paid: |
|
|
|
$79,209.05 |
|
|
|
In accordance with Section 14(g) of the Securities Exchange Act of 1934, as amended, the filing fee was calculated by multiplying .00003070 by the sum of: (a) the product of 55,411,265 shares of Company common stock and the per share merger consideration of $43.50 in cash per share of Company common stock, (b) the product of 1,649,963 shares of Company common stock underlying options and $30.31 (the difference between $43.50 and $13.19, the weighted average exercise price per share of Company common stock underlying the options), (c) the product of 538,033 shares of Company restricted stock units and the per share merger consideration of $43.50 in cash per share of Company common stock, and (d) the product of 2,213,669 shares subject to outstanding convertible debentures and the per share merger consideration of $43.50 in cash per share of Company common stock. |
|
o |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
|
|
(1) |
Amount Previously Paid: |
|
|
(2) |
Form, Schedule or Registration Statement No.: |
|
|
(3) |
Filing Party: |
|
|
(4) |
Date Filed: |

Sierra Health
Services, Inc
2724
North Tenaya Way
Las Vegas, Nevada 89128
[•], 2007
Dear Stockholder:
I am pleased to inform you that Sierra Health Services, Inc. and UnitedHealth Group Incorporated have entered into a definitive merger agreement pursuant to which UnitedHealth Group will acquire all of the outstanding shares of the Company’s common stock. If the merger is completed, the Company will become wholly owned by UnitedHealth Group and you will receive $43.50 in cash for each of your shares of our common stock. The $43.50 per share merger consideration represents a premium of approximately 21.2% over the closing price of $35.90 per share of our common stock on March 9, 2007, the last trading day prior to the announcement of the merger.
You are cordially invited to attend a special meeting of our stockholders to be held on [•] [•], 2007, at [•] a.m., Pacific Daylight Time, at [•] to vote on the approval of the merger agreement. As described in the enclosed proxy statement, the Company’s board of directors has unanimously adopted the merger agreement and declared that the merger and the merger agreement are advisable and in the best interests of the Company and its stockholders. The Company’s board of directors recommends that you vote “FOR” the approval of the merger agreement.
The Company cannot complete the merger unless the Company’s stockholders approve the merger agreement. Such approval requires the affirmative vote by the holders of a majority of the shares of our common stock outstanding on the record date. In connection with the Company entering into the merger agreement, I have agreed, in my capacity as a stockholder, to vote the shares of common stock I beneficially own (other than any shares of common stock as to which I act in a fiduciary capacity on behalf of persons other than members of my family), which shares represent approximately [8.0]% of the outstanding shares of the Company’s common stock, in favor of the approval of the merger agreement.
The notice of special meeting and the proxy statement that accompanies this letter provide you with extensive information about the merger agreement, the merger and the special meeting. We encourage you to read these materials carefully. You may also obtain more detailed information about the Company from documents that we have filed with the Securities and Exchange Commission.
Your vote is important. Whether or not you plan to attend the special meeting, please read the enclosed proxy statement and promptly complete, sign, date and return the enclosed proxy card in the postage-paid envelope provided or submit a proxy through the Internet or by telephone in accordance with the directions set forth on the proxy card. Your shares will then be represented at the special meeting. If you attend the special meeting, you may, by following the procedures discussed in the accompanying documents, vote in person notwithstanding the fact that you may have previously submitted or appointed a proxy. Thank you for your continued support.
|
Sincerely, |
|
|
|
|
|
|
Anthony M. Marlon, M.D. |
|
|
Chairman of the Board of Directors and |
|
|
Chief Executive Officer |
This transaction has not been approved or disapproved by the Securities and Exchange Commission, nor has the Securities and Exchange Commission passed upon the fairness or merits of this transaction or the accuracy or adequacy of the information contained in this proxy statement. Any representation to the contrary is unlawful.
This proxy statement is dated [•], 2007, and is first being mailed, along with the attached proxy card, to stockholders of the Company on or about [•], 2007.
NOTICE OF SPECIAL
MEETING OF STOCKHOLDERS
To Be Held on [•], 2007
To the Stockholders:
A special meeting of stockholders of Sierra Health Services, Inc. will be held on [•], 2007, at [•] a.m., Pacific Daylight Time, at [•], for the following purposes:
1. to consider and vote on the proposal to approve the Agreement and Plan of Merger, dated as of March 11, 2007, by and among UnitedHealth Group Incorporated (“UnitedHealth Group”), Sapphire Acquisition, Inc. (“Merger Sub”) and Sierra Health Services, Inc. (the “Company”), pursuant to which Merger Sub will be merged with and into the Company and the Company will become an indirect wholly-owned subsidiary of UnitedHealth Group (the “Merger”); and
2. to transact any other business as may properly come before the special meeting or at any adjournment of the special meeting.
The Company’s board of directors has determined that the merger agreement and the merger are advisable to and in the best interests of the Company and its stockholders and has unanimously adopted the merger agreement, the merger and the other transactions contemplated by the merger agreement. If the merger is completed, each issued and outstanding share of our common stock will be converted into the right to receive $43.50 in cash, without interest. Under Nevada law, no dissenters’ rights or rights of appraisal will apply in connection with the merger.
The merger is described in the accompanying proxy statement, which you are urged to read carefully. A copy of the merger agreement is attached to the proxy statement as Appendix A.
The Company’s board of directors has fixed the close of business on [•], 2007, as the record date for the determination of stockholders entitled to notice of and to vote at the special meeting. Accordingly, only stockholders of record on that date are entitled to vote at the special meeting or any adjournments thereof. A list of stockholders entitled to vote at the special meeting will be open for inspection by any stockholder at any time during usual business hours for a period of 5 days prior to the special meeting at the offices of the Company, 2724 North Tenaya Way, Las Vegas, Nevada 89128.
Approval of the merger agreement requires the affirmative vote by the holders of a majority of the shares of our common stock outstanding on the record date in accordance with Nevada law, our restated articles of incorporation and our amended and restated bylaws. Under the terms of a voting and support agreement (which will terminate upon the termination of the merger agreement), Anthony M. Marlon, M.D., the Chairman of our board of directors and our Chief Executive Officer, has agreed to vote the shares of our common stock he beneficially owns (other than any shares of our common stock as to which Dr. Marlon acts in a fiduciary capacity on behalf of persons other than members of his family) in favor of the approval of the merger agreement. Such shares represent approximately [8.0]% of the outstanding shares of our common stock.
The board of directors is not aware of any matters that may be brought before the special meeting other than those set forth in this Notice of Special Meeting of Stockholders. If other matters properly come before the special meeting, the persons named in the accompanying proxy card will vote the shares represented by all properly submitted proxies on such matters in accordance with any recommendation of the board of directors or, in the absence of such recommendation, in their discretion.
Whether or not you plan to attend the special meeting in person, please complete, sign, date and return the enclosed proxy card in the postage-paid envelope provided or appoint a proxy over the Internet or by telephone, in accordance with the directions set forth on the proxy card, to ensure that your shares will be represented at the special meeting. If you do attend the special meeting and wish to vote in person, you may do so notwithstanding the fact that you previously submitted or appointed a proxy. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain from your nominee a proxy issued in your name.
Please do not send your stock certificates at this time. If the merger is completed, you will be sent instructions regarding the surrender of your stock certificates.
The board of directors has unanimously adopted the merger agreement and recommends that our stockholders vote “FOR” the approval of the merger agreement.
|
|
By Order of the Board of Directors, |
|
|
|
|
|
Frank E. Collins |
|
|
Secretary |
Las Vegas, Nevada
[•], 2007
PROXY
STATEMENT
TABLE OF CONTENTS
|
|
Page |
|
|||
|
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER |
|
|
1 |
|
|
|
|
|
6 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
8 |
|
|
|
|
Share Ownership of Directors, Executive Officers and Certain Beneficial Owners |
|
|
8 |
|
|
|
Interests of the Company’s Directors, Executive Officers and Certain Beneficial Owners in the Merger |
|
|
8 |
|
|
|
|
|
9 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
|
|
||
|
|
|
11 |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
13 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
15 |
|
|
|
|
Voting by Directors, Executive Officers and Certain Record Holders |
|
|
16 |
|
|
|
|
|
16 |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
24 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
32 |
|
|
|
|
Effects on the Company and Our Stockholders If the Merger Is Not Completed |
|
|
33 |
|
|
|
|
|
33 |
|
|
|
i
|
Interests of the Company’s Directors, Executive Officers and Certain Beneficial Owners in the Merger |
|
|
34 |
|
|
|
|
|
34 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
37 |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
42 |
|
|
|
|
|
|
42 |
|
|
|
|
|
|
43 |
|
|
|
|
|
|
44 |
|
|
|
|
|
|
45 |
|
|
|
|
|
|
45 |
|